WebHIT complicates the management of patients presenting for cardiac surgery, particularly those who need cardiopulmonary bypass (CPB) which requires a large dose of UFH. A portion of these patients will have significant thrombotic complications referred to as HITT (Heparin-induced thrombocytopenia with thrombosis). WebNov 3, 2010 · Antiphospholipid syndrome (APLS) is a rare syndrome mainly characterized by several hyper-coagulable complications and therefore, implicated in the operated cardiac surgery patient. APLS comprises clinical features such as arterial or venous thromboses, valve disease, coronary artery disease, intracardiac thrombus …
Bivalirudin and post-cardiotomy ECMO: a word of caution
WebMar 11, 2004 · Drug: Angiomax (bivalirudin) 250 mg vial administered as 1.0 mg/kg intravenous (IV) bolus and 2.5 mg/kg/h IV infusion during the procedure with the option to administer additional 0.1 to 0.5 mg/kg boluses to increase the level of anticoagulation as clinically indicated. A low-dose infusion could have been administered in the preoperative … WebAnesthesia & Analgesia: June 2004 - Volume 98 - Issue 6 - p 1635-1639. doi: 10.1213/01.ANE.0000114072.71353.D5. Free. We treated persistent hemorrhage after cardiopulmonary bypass in a heart transplant recipient who had received anticoagulation with the direct thrombin inhibitor bivalirudin by a combination therapy aimed at reducing … fmb board of directors
Bivalirudin resistance during heart transplantation surgery.
WebThe hypothesis that dabigatran would provide sufficient anticoagulation for cardiopulmonary bypass was tested in a first-use, proof-of-concept study using a rabbit … WebThis case report showed a favourable outcome with bivalirudin for urgent complex redo cardiac surgery requiring CPB. Bivalirudin is a DTI, which can be used as an alternative anticoagulant for CPB in HIT positive patients. ... Anticoagulation for cardiopulmonary bypass (CPB) was achieved with the use of a direct thrombin inhibitor (DTI ... WebA total of 21 adult patients received bivalirudin with infusion rates ranging from 0.028 to 0.2 mg/kg/h with or without initial bolus doses. 10 This wide variability in dosing requirements was also observed in our present analysis with maintenance rates achieving target aPTT ranges of 0.04 to 0.26 mg/kg/h. greensboro nc building permit